Edgemond James, CFO and Treasurer of United Therapeutics Corp (UTHR), sold shares on the open market 83 times in the last 365 days, totaling $68.2 million. His most recent sale occurred on December 15, 2025. These sales rank 228th among 11,678 insiders in our database, surpassing the average of $8.6 million per insider and 6.4 transactions. James made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $592.12 | 22,989.0000 | 48,100,000 | 0.52% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1487 | $588.42 | 25,812.0000 | 48,100,000 | 5.45% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 500 | $595.91 | 21,833.0000 | 48,100,000 | 2.24% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10000 | $135.42 | 28,876.0000 | 48,100,000 | 52.98% | 0.02% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 40 | $581.73 | 28,836.0000 | 48,100,000 | 0.14% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $583.52 | 28,716.0000 | 48,100,000 | 0.42% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $585.17 | 28,596.0000 | 48,100,000 | 0.42% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 437 | $586.27 | 28,159.0000 | 48,100,000 | 1.53% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 860 | $587.35 | 27,299.0000 | 48,100,000 | 3.05% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1196 | $589.23 | 24,616.0000 | 48,100,000 | 4.63% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1026 | $590.36 | 23,590.0000 | 48,100,000 | 4.17% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 481 | $591.26 | 23,109.0000 | 48,100,000 | 2.04% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 176 | $593.68 | 22,813.0000 | 48,100,000 | 0.77% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 480 | $594.74 | 22,333.0000 | 48,100,000 | 2.10% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 10000 | $0.00 | 132,500.0000 | 48,100,000 | 7.02% | 0.02% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 21 | $606.53 | 18,876.0000 | 48,100,000 | 0.11% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 770 | $604.64 | 18,897.0000 | 48,100,000 | 3.92% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 103 | $603.69 | 19,667.0000 | 48,100,000 | 0.52% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 417 | $602.53 | 19,770.0000 | 48,100,000 | 2.07% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 212 | $601.43 | 20,187.0000 | 48,100,000 | 1.04% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 790 | $599.82 | 20,399.0000 | 48,100,000 | 3.73% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 200 | $598.83 | 21,189.0000 | 48,100,000 | 0.94% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 240 | $597.72 | 21,389.0000 | 48,100,000 | 1.11% | 0.00% |
| March 30, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 204 | $596.74 | 21,629.0000 | 48,100,000 | 0.93% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 609 | $533.91 | 26,766.0000 | 48,100,000 | 2.22% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10000 | $135.42 | 28,876.0000 | 48,100,000 | 52.98% | 0.02% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2003 | $535.94 | 22,916.0000 | 48,100,000 | 8.04% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 991 | $532.02 | 27,885.0000 | 48,100,000 | 3.43% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 510 | $532.93 | 27,375.0000 | 48,100,000 | 1.83% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1847 | $534.98 | 24,919.0000 | 48,100,000 | 6.90% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1577 | $536.90 | 21,339.0000 | 48,100,000 | 6.88% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1149 | $537.90 | 20,190.0000 | 48,100,000 | 5.38% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 994 | $538.91 | 19,196.0000 | 48,100,000 | 4.92% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 320 | $540.04 | 18,876.0000 | 48,100,000 | 1.67% | 0.00% |
| March 26, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 10000 | $0.00 | 142,500.0000 | 48,100,000 | 6.56% | 0.02% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 642 | $533.60 | 19,982.0000 | 48,100,000 | 3.11% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10000 | $135.42 | 28,876.0000 | 48,100,000 | 52.98% | 0.02% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 200 | $518.28 | 28,676.0000 | 48,100,000 | 0.69% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 640 | $519.30 | 28,036.0000 | 48,100,000 | 2.23% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 875 | $520.62 | 27,161.0000 | 48,100,000 | 3.12% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 905 | $521.47 | 26,256.0000 | 48,100,000 | 3.33% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 200 | $522.36 | 26,056.0000 | 48,100,000 | 0.76% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 440 | $524.20 | 25,616.0000 | 48,100,000 | 1.69% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 320 | $525.37 | 25,296.0000 | 48,100,000 | 1.25% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 520 | $526.57 | 24,776.0000 | 48,100,000 | 2.06% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 80 | $527.49 | 24,696.0000 | 48,100,000 | 0.32% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2620 | $529.04 | 22,076.0000 | 48,100,000 | 10.61% | 0.01% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 577 | $530.64 | 21,499.0000 | 48,100,000 | 2.61% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 587 | $531.49 | 20,912.0000 | 48,100,000 | 2.73% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 288 | $532.59 | 20,624.0000 | 48,100,000 | 1.38% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 506 | $534.60 | 19,476.0000 | 48,100,000 | 2.53% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 440 | $535.34 | 19,036.0000 | 48,100,000 | 2.26% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 160 | $536.28 | 18,876.0000 | 48,100,000 | 0.84% | 0.00% |
| March 23, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 10000 | $0.00 | 152,500.0000 | 48,100,000 | 6.15% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10380 | $0.00 | 18,564.0000 | 48,100,000 | 126.83% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Restricted Stock Units | 9098 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Restricted Stock Units | 10380 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | F | Common Stock | 4104 | $536.12 | 18,876.0000 | 48,100,000 | 17.86% | 0.01% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | F | Common Stock | 4682 | $536.12 | 22,980.0000 | 48,100,000 | 16.93% | 0.01% |
| March 15, 2026 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 9098 | $0.00 | 27,662.0000 | 48,100,000 | 49.01% | 0.02% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | A | Restricted Stock Units | 10380 | $0.00 | 10,380.0000 | 48,500,000 | 9999.99% | 0.02% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | A | Restricted Stock Units | 9098 | $0.00 | 9,098.0000 | 48,500,000 | 9999.99% | 0.02% |
| March 15, 2023 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | A | Stock Options | 58170 | $0.00 | 58,170.0000 | 48,500,000 | 9999.99% | 0.12% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 3517 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.01% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 241 | $500.30 | 8,142.0000 | 48,100,000 | 2.87% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 240 | $499.31 | 8,383.0000 | 48,100,000 | 2.78% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 395 | $498.09 | 8,623.0000 | 48,100,000 | 4.38% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 200 | $496.97 | 9,018.0000 | 48,100,000 | 2.17% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 520 | $495.90 | 9,218.0000 | 48,100,000 | 5.34% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 360 | $495.02 | 9,738.0000 | 48,100,000 | 3.57% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 561 | $493.70 | 10,098.0000 | 48,100,000 | 5.26% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 840 | $492.81 | 10,659.0000 | 48,100,000 | 7.30% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 160 | $491.53 | 11,499.0000 | 48,100,000 | 1.37% | 0.00% |
| Dec. 15, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3517 | $146.03 | 11,659.0000 | 48,100,000 | 43.20% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3139 | $479.16 | 12,822.0000 | 48,100,000 | 19.67% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 21000 | $0.00 | 3,517.0000 | 48,100,000 | 85.65% | 0.04% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 520 | $486.71 | 8,142.0000 | 48,100,000 | 6.00% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $484.85 | 8,662.0000 | 48,100,000 | 1.37% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 739 | $484.51 | 8,782.0000 | 48,100,000 | 7.76% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 742 | $483.29 | 9,521.0000 | 48,100,000 | 7.23% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 523 | $482.22 | 10,263.0000 | 48,100,000 | 4.85% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 477 | $481.22 | 10,786.0000 | 48,100,000 | 4.24% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1559 | $480.03 | 11,263.0000 | 48,100,000 | 12.16% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3295 | $477.97 | 15,961.0000 | 48,100,000 | 17.11% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 6529 | $477.18 | 19,256.0000 | 48,100,000 | 25.32% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2957 | $476.17 | 25,785.0000 | 48,100,000 | 10.29% | 0.01% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 400 | $475.08 | 28,742.0000 | 48,100,000 | 1.37% | 0.00% |
| Dec. 8, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 21000 | $146.03 | 29,142.0000 | 48,100,000 | 257.92% | 0.04% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2853 | $477.98 | 26,289.0000 | 48,100,000 | 9.79% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 20483 | $0.00 | 24,517.0000 | 48,100,000 | 45.52% | 0.04% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 517 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 160 | $484.68 | 8,142.0000 | 48,100,000 | 1.93% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 903 | $483.04 | 8,302.0000 | 48,100,000 | 9.81% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 21000 | $146.03 | 29,142.0000 | 48,100,000 | 257.92% | 0.04% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1476 | $481.80 | 9,205.0000 | 48,100,000 | 13.82% | 0.00% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3858 | $480.95 | 10,681.0000 | 48,100,000 | 26.54% | 0.01% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 7552 | $479.92 | 14,539.0000 | 48,100,000 | 34.19% | 0.02% |
| Dec. 1, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 4198 | $479.11 | 22,091.0000 | 48,100,000 | 15.97% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2989 | $477.22 | 11,652.0000 | 48,100,000 | 20.42% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1621 | $476.09 | 14,641.0000 | 48,100,000 | 9.97% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1560 | $475.11 | 16,262.0000 | 48,100,000 | 8.75% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 280 | $473.54 | 17,822.0000 | 48,100,000 | 1.55% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1788 | $472.73 | 18,102.0000 | 48,100,000 | 8.99% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1971 | $471.88 | 19,890.0000 | 48,100,000 | 9.02% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1552 | $469.34 | 24,780.0000 | 48,100,000 | 5.89% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2919 | $470.22 | 21,861.0000 | 48,100,000 | 11.78% | 0.01% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1850 | $468.29 | 26,332.0000 | 48,100,000 | 6.56% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 960 | $467.35 | 28,182.0000 | 48,100,000 | 3.29% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 21000 | $146.03 | 29,142.0000 | 48,100,000 | 257.92% | 0.04% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 21000 | $0.00 | 517.0000 | 48,100,000 | 97.60% | 0.04% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 131 | $482.29 | 8,142.0000 | 48,100,000 | 1.58% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 794 | $481.55 | 8,273.0000 | 48,100,000 | 8.76% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 640 | $480.71 | 9,067.0000 | 48,100,000 | 6.59% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 315 | $478.73 | 9,707.0000 | 48,100,000 | 3.14% | 0.00% |
| Nov. 24, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1630 | $478.14 | 10,022.0000 | 48,100,000 | 13.99% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 4107 | $468.33 | 13,113.0000 | 48,100,000 | 23.85% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 10688 | $0.00 | 21,517.0000 | 48,100,000 | 33.19% | 0.02% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 10312 | $0.00 | 0.0000 | 48,100,000 | 100.00% | 0.02% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 437 | $470.34 | 8,118.0000 | 48,100,000 | 5.11% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 4558 | $469.39 | 8,555.0000 | 48,100,000 | 34.76% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1090 | $467.53 | 17,220.0000 | 48,100,000 | 5.95% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $464.38 | 18,310.0000 | 48,100,000 | 0.65% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10312 | $146.03 | 18,430.0000 | 48,100,000 | 127.03% | 0.02% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 84 | $476.47 | 8,118.0000 | 48,100,000 | 1.02% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 798 | $475.89 | 8,202.0000 | 48,100,000 | 8.87% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 639 | $474.80 | 9,000.0000 | 48,100,000 | 6.63% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 920 | $473.68 | 9,639.0000 | 48,100,000 | 8.71% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1999 | $472.13 | 10,559.0000 | 48,100,000 | 15.92% | 0.00% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2657 | $471.22 | 12,558.0000 | 48,100,000 | 17.46% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3591 | $470.34 | 15,215.0000 | 48,100,000 | 19.09% | 0.01% |
| Nov. 17, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 10688 | $146.03 | 18,806.0000 | 48,100,000 | 131.66% | 0.02% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 4633 | $453.81 | 14,050.0000 | 48,100,000 | 24.80% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2170 | $452.76 | 18,683.0000 | 48,100,000 | 10.41% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1065 | $451.87 | 20,853.0000 | 48,100,000 | 4.86% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 21000 | $0.00 | 10,312.0000 | 48,100,000 | 67.07% | 0.04% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 21000 | $146.03 | 29,118.0000 | 48,100,000 | 258.68% | 0.04% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1052 | $446.51 | 28,066.0000 | 48,100,000 | 3.61% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1539 | $447.47 | 26,527.0000 | 48,100,000 | 5.48% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3356 | $448.33 | 23,171.0000 | 48,100,000 | 12.65% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 653 | $449.00 | 22,518.0000 | 48,100,000 | 2.82% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 600 | $450.80 | 21,918.0000 | 48,100,000 | 2.66% | 0.00% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2590 | $455.83 | 8,118.0000 | 48,100,000 | 24.19% | 0.01% |
| Nov. 10, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3342 | $454.82 | 10,708.0000 | 48,100,000 | 23.79% | 0.01% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1074 | $432.86 | 27,946.0000 | 48,100,000 | 3.70% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1679 | $434.96 | 24,755.0000 | 48,100,000 | 6.35% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 6088 | $435.81 | 18,667.0000 | 48,100,000 | 24.59% | 0.01% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2752 | $437.74 | 8,598.0000 | 48,100,000 | 24.25% | 0.01% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 360 | $438.50 | 8,238.0000 | 48,100,000 | 4.19% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 120 | $439.51 | 8,118.0000 | 48,100,000 | 1.46% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 21000 | $0.00 | 31,312.0000 | 48,100,000 | 40.14% | 0.04% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 21000 | $146.03 | 29,118.0000 | 48,100,000 | 258.68% | 0.04% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 98 | $432.09 | 29,020.0000 | 48,100,000 | 0.34% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1512 | $433.78 | 26,434.0000 | 48,100,000 | 5.41% | 0.00% |
| Nov. 4, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 7317 | $436.78 | 11,350.0000 | 48,100,000 | 39.20% | 0.02% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 12000 | $0.00 | 87,500.0000 | 48,500,000 | 12.06% | 0.02% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 12000 | $117.76 | 20,118.0000 | 48,500,000 | 147.82% | 0.02% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3595 | $325.44 | 16,523.0000 | 48,500,000 | 17.87% | 0.01% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 305 | $326.56 | 16,218.0000 | 48,500,000 | 1.85% | 0.00% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 100 | $328.28 | 16,118.0000 | 48,500,000 | 0.62% | 0.00% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 7700 | $325.20 | 8,418.0000 | 48,500,000 | 47.77% | 0.02% |
| June 9, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 300 | $326.81 | 8,118.0000 | 48,500,000 | 3.56% | 0.00% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 1397 | $326.34 | 16,118.0000 | 48,500,000 | 7.98% | 0.00% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Option | 12000 | $0.00 | 99,500.0000 | 48,500,000 | 10.76% | 0.02% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2653 | $326.31 | 8,118.0000 | 48,500,000 | 24.63% | 0.01% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 5347 | $325.59 | 10,771.0000 | 48,500,000 | 33.17% | 0.01% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 2603 | $325.54 | 17,515.0000 | 48,500,000 | 12.94% | 0.01% |
| June 2, 2025 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 12000 | $117.76 | 20,118.0000 | 48,500,000 | 147.82% | 0.02% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 10,912.0000 | 48,500,000 | 45.26% | 0.01% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 10,779.0000 | 48,500,000 | 43.49% | 0.01% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $374.02 | 7,512.0000 | 48,500,000 | 30.31% | 0.01% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 111,500.0000 | 48,500,000 | 0.76% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 0.0000 | 48,500,000 | 100.00% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 112,350.0000 | 48,500,000 | 2.94% | 0.01% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 817.0000 | 48,500,000 | 80.00% | 0.01% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 565 | $374.02 | 8,068.0000 | 48,500,000 | 6.54% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 8,633.0000 | 48,500,000 | 10.92% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 546 | $374.02 | 7,783.0000 | 48,500,000 | 6.56% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 8,329.0000 | 48,500,000 | 10.88% | 0.00% |
| Nov. 4, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $374.02 | 7,512.0000 | 48,500,000 | 31.16% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 4,901.0000 | 48,500,000 | 40.00% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 10,245.0000 | 48,500,000 | 46.82% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $350.00 | 6,978.0000 | 48,500,000 | 31.89% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 10,378.0000 | 48,500,000 | 48.72% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $350.00 | 6,978.0000 | 48,500,000 | 32.76% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 7,795.0000 | 48,500,000 | 11.71% | 0.00% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 557 | $350.00 | 7,238.0000 | 48,500,000 | 7.15% | 0.00% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 8,088.0000 | 48,500,000 | 11.74% | 0.00% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 576 | $350.00 | 7,512.0000 | 48,500,000 | 7.12% | 0.00% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 116,600.0000 | 48,500,000 | 2.83% | 0.01% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 4,084.0000 | 48,500,000 | 16.67% | 0.00% |
| Oct. 28, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 115,750.0000 | 48,500,000 | 0.73% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 120,000.0000 | 48,500,000 | 0.70% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 567 | $366.99 | 6,978.0000 | 48,500,000 | 7.51% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 8,985.0000 | 48,500,000 | 26.67% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 548 | $366.99 | 6,695.0000 | 48,500,000 | 7.57% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 120,850.0000 | 48,500,000 | 2.74% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 8,168.0000 | 48,500,000 | 9.09% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 7,243.0000 | 48,500,000 | 12.71% | 0.00% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $366.99 | 6,426.0000 | 48,500,000 | 34.60% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 9,826.0000 | 48,500,000 | 52.91% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $366.99 | 6,426.0000 | 48,500,000 | 33.70% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 9,693.0000 | 48,500,000 | 50.84% | 0.01% |
| Oct. 21, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 7,545.0000 | 48,500,000 | 12.70% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 12,252.0000 | 48,500,000 | 6.25% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 9,151.0000 | 48,500,000 | 55.52% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $355.88 | 5,884.0000 | 48,500,000 | 35.70% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $177.76 | 9,284.0000 | 48,500,000 | 57.78% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $355.88 | 5,884.0000 | 48,500,000 | 36.62% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 6,701.0000 | 48,500,000 | 13.89% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 553 | $355.88 | 6,148.0000 | 48,500,000 | 8.25% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 6,998.0000 | 48,500,000 | 13.83% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 572 | $355.88 | 6,426.0000 | 48,500,000 | 8.17% | 0.00% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 13,069.0000 | 48,500,000 | 20.00% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 125,100.0000 | 48,500,000 | 2.65% | 0.01% |
| Oct. 14, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 124,250.0000 | 48,500,000 | 0.68% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 554 | $355.54 | 5,607.0000 | 48,500,000 | 8.99% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 8,611.0000 | 48,500,000 | 61.13% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $355.54 | 5,344.0000 | 48,500,000 | 37.94% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 8,744.0000 | 48,500,000 | 63.62% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $355.54 | 5,344.0000 | 48,500,000 | 38.88% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 6,161.0000 | 48,500,000 | 15.29% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 6,457.0000 | 48,500,000 | 15.16% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 573 | $355.54 | 5,884.0000 | 48,500,000 | 8.87% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 17,153.0000 | 48,500,000 | 16.00% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 129,350.0000 | 48,500,000 | 2.56% | 0.01% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 16,336.0000 | 48,500,000 | 4.76% | 0.00% |
| Oct. 7, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 128,500.0000 | 48,500,000 | 0.66% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 132,750.0000 | 49,700,000 | 0.64% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 8,069.0000 | 49,700,000 | 68.03% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $358.62 | 4,802.0000 | 49,700,000 | 40.49% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 8,202.0000 | 49,700,000 | 70.80% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $358.62 | 4,802.0000 | 49,700,000 | 41.45% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 5,619.0000 | 49,700,000 | 17.01% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 553 | $358.62 | 5,066.0000 | 49,700,000 | 9.84% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 5,916.0000 | 49,700,000 | 16.78% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 572 | $358.62 | 5,344.0000 | 49,700,000 | 9.67% | 0.00% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 21,237.0000 | 49,700,000 | 13.33% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 133,600.0000 | 49,700,000 | 2.48% | 0.01% |
| Sept. 30, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 20,420.0000 | 49,700,000 | 3.85% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 137,000.0000 | 49,700,000 | 0.62% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 7,531.0000 | 49,700,000 | 76.62% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $354.04 | 4,264.0000 | 49,700,000 | 43.38% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 7,664.0000 | 49,700,000 | 79.74% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $354.04 | 4,264.0000 | 49,700,000 | 44.36% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 5,081.0000 | 49,700,000 | 19.16% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 5,376.0000 | 49,700,000 | 18.78% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 574 | $354.04 | 4,802.0000 | 49,700,000 | 10.68% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 25,321.0000 | 49,700,000 | 11.43% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 137,850.0000 | 49,700,000 | 2.41% | 0.01% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 24,504.0000 | 49,700,000 | 3.23% | 0.00% |
| Sept. 23, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 555 | $354.04 | 4,526.0000 | 49,700,000 | 10.92% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 7,140.0000 | 49,700,000 | 90.91% | 0.01% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 141,250.0000 | 49,700,000 | 0.60% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 817 | $0.00 | 28,588.0000 | 49,700,000 | 2.78% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 142,100.0000 | 49,700,000 | 2.34% | 0.01% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3267 | $0.00 | 29,405.0000 | 49,700,000 | 10.00% | 0.01% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 581 | $339.12 | 4,264.0000 | 49,700,000 | 11.99% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 4,845.0000 | 49,700,000 | 21.28% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 562 | $339.12 | 3,995.0000 | 49,700,000 | 12.33% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 817 | $120.26 | 4,557.0000 | 49,700,000 | 21.84% | 0.00% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $339.12 | 3,740.0000 | 49,700,000 | 47.62% | 0.01% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3267 | $339.12 | 3,740.0000 | 49,700,000 | 46.62% | 0.01% |
| Sept. 16, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3267 | $120.26 | 7,007.0000 | 49,700,000 | 87.35% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 145,500.0000 | 49,700,000 | 0.58% | 0.00% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3266 | $120.26 | 6,476.0000 | 49,700,000 | 101.74% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3266 | $345.41 | 3,210.0000 | 49,700,000 | 50.43% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 6,610.0000 | 49,700,000 | 105.92% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $345.41 | 3,210.0000 | 49,700,000 | 51.44% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 816 | $120.26 | 4,026.0000 | 49,700,000 | 25.42% | 0.00% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 558 | $345.41 | 3,468.0000 | 49,700,000 | 13.86% | 0.00% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 4,318.0000 | 49,700,000 | 24.51% | 0.00% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 578 | $345.41 | 3,740.0000 | 49,700,000 | 13.39% | 0.00% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3266 | $0.00 | 33,488.0000 | 49,700,000 | 8.89% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 146,350.0000 | 49,700,000 | 2.27% | 0.01% |
| Sept. 9, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 816 | $0.00 | 32,672.0000 | 49,700,000 | 2.44% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 816 | $0.00 | 36,754.0000 | 49,700,000 | 2.17% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3266 | $120.26 | 5,881.0000 | 49,700,000 | 124.89% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3266 | $362.37 | 2,615.0000 | 49,700,000 | 55.53% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 6,015.0000 | 49,700,000 | 130.02% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $362.37 | 2,615.0000 | 49,700,000 | 56.53% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 816 | $120.26 | 3,431.0000 | 49,700,000 | 31.20% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 550 | $362.37 | 2,881.0000 | 49,700,000 | 16.03% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 3,731.0000 | 49,700,000 | 29.50% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 569 | $362.37 | 3,162.0000 | 49,700,000 | 15.25% | 0.00% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3266 | $0.00 | 37,570.0000 | 49,700,000 | 8.00% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 150,600.0000 | 49,700,000 | 2.21% | 0.01% |
| Sept. 3, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 149,750.0000 | 49,700,000 | 0.56% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3266 | $0.00 | 41,652.0000 | 49,700,000 | 7.27% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3266 | $120.26 | 5,348.0000 | 49,700,000 | 156.87% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3266 | $347.60 | 2,082.0000 | 49,700,000 | 61.07% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 5,482.0000 | 49,700,000 | 163.30% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $347.60 | 2,082.0000 | 49,700,000 | 62.02% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 816 | $120.26 | 2,898.0000 | 49,700,000 | 39.19% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 557 | $347.60 | 2,341.0000 | 49,700,000 | 19.22% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 3,191.0000 | 49,700,000 | 36.31% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 576 | $347.60 | 2,615.0000 | 49,700,000 | 18.05% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 154,850.0000 | 49,700,000 | 2.15% | 0.01% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 816 | $0.00 | 40,836.0000 | 49,700,000 | 1.96% | 0.00% |
| Aug. 26, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 154,000.0000 | 49,700,000 | 0.55% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 850 | $0.00 | 158,250.0000 | 49,700,000 | 0.53% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3266 | $120.26 | 4,844.0000 | 49,700,000 | 206.97% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3266 | $329.02 | 1,578.0000 | 49,700,000 | 67.42% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 3400 | $117.76 | 4,978.0000 | 49,700,000 | 215.46% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 3400 | $329.02 | 1,578.0000 | 49,700,000 | 68.30% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 816 | $120.26 | 2,394.0000 | 49,700,000 | 51.71% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 571 | $329.02 | 1,823.0000 | 49,700,000 | 23.85% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 850 | $117.76 | 2,673.0000 | 49,700,000 | 46.63% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 591 | $329.02 | 2,082.0000 | 49,700,000 | 22.11% | 0.00% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3266 | $0.00 | 45,734.0000 | 49,700,000 | 6.67% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 3400 | $0.00 | 159,100.0000 | 49,700,000 | 2.09% | 0.01% |
| Aug. 19, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Stock Options | 816 | $0.00 | 44,918.0000 | 49,700,000 | 1.78% | 0.00% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 15160 | $272.69 | 1,578.0000 | 49,700,000 | 90.57% | 0.03% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 25000 | $163.30 | 26,578.0000 | 49,700,000 | 1584.28% | 0.05% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | S | Common Stock | 25000 | $272.69 | 1,578.0000 | 49,700,000 | 94.06% | 0.05% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Share Tracking Award | 15160 | $0.00 | 0.0000 | 49,700,000 | 100.00% | 0.03% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Common Stock | 15160 | $163.30 | 16,738.0000 | 49,700,000 | 960.71% | 0.03% |
| May 15, 2024 | UNITED THERAPEUTICS Corp | $UTHR | EDGEMOND JAMES | CFO AND TREASURER | M | Share Tracking Award | 25000 | $0.00 | 0.0000 | 49,700,000 | 100.00% | 0.05% |